Cargando…

Tolerability of Ziprasidone Use in Children and Adolescents: A Prisma Model: Systematic Review and Meta-Analysis

INTRODUCTION: Studies have demonstrated that Ziprasidone use may be beneficial in children. Determining its potential risks and benefits when used in children is therefore important. OBJECTIVES: To examine the tolerability of Ziprasidone, an atypical antipsychotic, in children and adolescents. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jay, J., Sareen, A., Hassan, N., Dumlao, N., Jose, K., Haza, I., Wadhwa, A., Gunturu, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566988/ http://dx.doi.org/10.1192/j.eurpsy.2022.383

Ejemplares similares

Efficacy and Tolerability of Ziprasidone Use in Children and Adolescents, a Systemic Review and Meta Analysis
por: Wadhwa, A., et al.
Publicado: (2022)

Ziprasidone in the Treatment of Delusional Parasitosis
por: Contreras-Ferrer, P., et al.
Publicado: (2012)

Emerging treatment options in bipolar disorder in adolescents: focus on ziprasidone
por: Khan, Afshan A, et al.
Publicado: (2010)

Improving quality of life with nutritional supplementation in Schizophrenia: A literature review
por: Hassan, N., et al.
Publicado: (2022)

PM395. The Effectiveness of Cross-Tapering Switching to Ziprasidone in Patients with Schizophrenia or Schizoaffective Disorder
por: Na, Kyoungsae, et al.
Publicado: (2016)

A Systematic Review and Case Series of Ziprasidone for Psychosis in Parkinson’s Disease
por: Younce, John R., et al.
Publicado: (2019)

Ziprasidone in the treatment of mania in bipolar disorder
por: Nicolson, Stephen E, et al.
Publicado: (2007)

Ziprasidone Associated Neuroleptic Malignant Syndrome
por: Bell, Jeffrey D., et al.
Publicado: (2021)

TMS use in Depressive disorder in Youth
por: Wadhwa, A., et al.
Publicado: (2022)

A Case Report of Priapism Caused by Ziprasidon
por: Karamustafalioglu, Nesrin, et al.
Publicado: (2013)

Ziprasidone Hydrocloride: What Role in the Management of Schizophrenia?
por: Mattei, Chiara, et al.
Publicado: (2011)

MON-675 Ziprasidone Induced Diabetic Ketoacidosis
por: Thanikonda, Varshitha, et al.
Publicado: (2020)

Evaluation of intramuscular olanzapine and ziprasidone in the medically ill
por: Patel, Seema M., et al.
Publicado: (2021)

Conventional intramuscular sedatives versus ziprasidone for severe agitation in adolescents: case-control study
por: Jangro, William C, et al.
Publicado: (2009)

Nonisothermal Kinetics Analysis of the Dehydration of Ziprasidone Hydrochloride Monohydrate by Thermogravimetry
por: Ravikiran, A., et al.
Publicado: (2013)

Evidence review and clinical guidance for the use of ziprasidone in Canada
por: Gardner, David M, et al.
Publicado: (2013)

Case Report: Ziprasidone induced neuroleptic malignant syndrome
por: Sedhai, Yub Raj, et al.
Publicado: (2021)

PS153. Efficacy of ziprasidone monotherapy in patients with anxious depression: A 12-week, randomized, double-blind, placebo-controlled, sequential-parallel comparison trial
por: Heo, Jung Yoon, et al.
Publicado: (2016)

Ziprasidone as Adjunctive Therapy in Severe Bipolar Patients Treated with Clozapine
por: Bartolommei, Natalia, et al.
Publicado: (2014)

Failed efficacy of ziprasidone in the treatment of post-traumatic stress disorder
por: Ramaswamy, Sriram, et al.
Publicado: (2015)

Efficacy of Ziprasidone in Controlling Agitation during Post-Traumatic Amnesia
por: Noé, Enrique, et al.
Publicado: (2007)

Human Hemoglobin and Antipsychotics Clozapine, Ziprasidone and Sertindole: Friends or Foes?
por: Platanić Arizanović, Lena, et al.
Publicado: (2023)

The Impact of Bilingualism on Executive Functions in Children and Adolescents: A Systematic Review Based on the PRISMA Method
por: Giovannoli, Jasmine, et al.
Publicado: (2020)

Memory deficits in children and adolescents with psychotic disorders: A systematic review and meta-analysis
por: Rodríguez Toscano, E., et al.
Publicado: (2023)

Comparison of Efficacy and Safety Between Low-Dose Ziprasidone in Combination With Sertraline and Ziprasidone Monotherapy for Treatment-Resistant Patients With Acute Exacerbation Schizophrenia: A Randomized Controlled Trial
por: Shi, Hui, et al.
Publicado: (2022)

Ziprasidone and its Association with Sudden Cardiac Death - A Case Report
por: Sidana, Ajeet, et al.
Publicado: (2004)

Behavioral and Metabolic Effects of the Atypical Antipsychotic Ziprasidone on the Nematode Caenorhabditis elegans
por: Gubert, Priscila, et al.
Publicado: (2013)

The Effectiveness of Cross-Tapering Switching to Ziprasidone in Patients with Schizophrenia or Schizoaffective Disorder
por: Ko, Young-Hoon, et al.
Publicado: (2014)

Ziprasidone-Induced Oculogyric Crisis in a 74-Year-Old Female
por: Wilson, Alphonso, et al.
Publicado: (2020)

Restless legs syndrome following the use of ziprasidone: a case report
por: Zhu, Cuizhen, et al.
Publicado: (2020)

Blinded by PRISMA: Are Systematic Reviewers Focusing on PRISMA and Ignoring Other Guidelines?
por: Fleming, Padhraig S., et al.
Publicado: (2014)

PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews
por: Rethlefsen, Melissa L., et al.
Publicado: (2021)

PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews(*)
por: Rethlefsen, Melissa L., et al.
Publicado: (2021)

F53. DOSE REDUCTION OF HIGH-DOSE FIRST-GENERATION ANTIPSYCHOTICS OR SWITCH TO ZIPRASIDONE IN LONG-STAY PATIENTS WITH SCHIZOPHRENIA: A 1-YEAR DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL
por: Bogers, Jan, et al.
Publicado: (2018)

To Be or Not to Be: Addressing of PRISMA Checklist for Reporting Systematic Reviews and Meta-Analyses
por: Amiri, Fatemeh, et al.
Publicado: (2023)

PRISMA-Children (C) and PRISMA-Protocol for Children (P-C) Extensions: a study protocol for the development of guidelines for the conduct and reporting of systematic reviews and meta-analyses of newborn and child health research
por: Kapadia, Mufiza Z, et al.
Publicado: (2016)

Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial
por: Kjelby, Eirik, et al.
Publicado: (2011)

1676. PK, Safety and Tolerability of VABOMERE(®) (meropenem-vaborbactam) in Infants, Children and Adolescents
por: Bokesch, Paula M, et al.
Publicado: (2023)

The effects of metformin on insulin resistance in overweight or obese children and adolescents: A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials
por: Sun, Juan, et al.
Publicado: (2019)

Working With Communities to Support Minority Caregivers: The PRISMA Health REACH Expansion Project
por: Spencer, Mindi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jrdvehkhuq3j4g6b9hicmso7v7